Rethink Your People Strategy for a Recovering but Volatile Biopharma Market: Navigate Immigration Complexity, Build Commercial Readiness & Get Ahead of the Turnover Wave Before It Hits - With Peers Who Are Running the Same Race
Running a lean HR function inside a clinical-stage biopharma company is unlike anything else in the industry. HR leaders are making decisions that affect drug development timelines, culture in the face of clinical failure, talent acquisition in a market where everyone is hiring the same rare disease specialists, and workforce planning with a cash runway measured in months. The playbooks from big pharma don't apply and the strategies from other industries don't translate. What HR leaders in emerging biopharma need is a room full of people who are and have been exactly where they are.
Now in its 6th edition, LEAP HR: Emerging Biopharma returns to Boston this December as the only event dedicated exclusively to the strategic people challenges facing HR leaders at emerging biopharma companies.
Among the Most Future-Focused C-Suite HR Leaders Sharing Case Studies in 2025
Attending Companies Include